Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$126.46 - $235.05 $221,431 - $411,572
-1,751 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $248,176 - $404,992
-1,099 Reduced 38.56%
1,751 $445,000
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $144,235 - $314,905
650 Added 29.55%
2,850 $1.1 Million
Q2 2021

Aug 09, 2021

BUY
$129.91 - $234.98 $285,802 - $516,956
2,200 New
2,200 $517,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Avidian Wealth Solutions, LLC Portfolio

Follow Avidian Wealth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.